JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gram, T. E.
Right arrow Articles by Fouts, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gram, T. E.
Right arrow Articles by Fouts, J. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 2, 435-445, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF PRETREATMENT OF RABBITS WITH PHENOBARBITAL OR 3-METHYLCHOLANTHRENE ON THE DISTRIBUTION OF DRUG-METABOLIZING ENZYME ACTIVITY IN SUBFRACTIONS OF HEPATIC MICROSOMES

Theodore E. Gram 1, Larry A. Rogers 1, and James R. Fouts 1

1 Department of Pharmacology, University of Iowa, Iowa City, Iowa

Hepatic microsomes from control, phenobarbital-, and 3-methylchol-anthrene (3-MC)-pretreated rabbits have been separated into rough-surfaced microsomal subfractions (RSM) and smooth-surfaced microsomal subfraetions (SSM), and the drug- metabolizing enzyme activity of the subfractions has been determined. Depending upon the substrate studied, phenobarbitai pretreatment resulted in either no change in levels of drug-metabolizing enzyme activity or caused significant increases in levels of activity. Phenobarbital-induced increases in enzyme activity were generally seen to occur in both SSM and RSM. The effects of 3-MC pretreatment, however, were either increases or decreases in enzyme activity, depending upon the enzyme pathway studied. These effects were generally seen in one microsomal subfraction or the other but not in both fractions. When decreases in activity were observed after 3-MC, they were always seen in the SSM. Electron micrographs of microsomal subfractions showed that pretreatment of rabbits with phenobarbital did not significantly change the purity of the two subfractions. 3-MC administration was associated with an apparent change in time sedimentation characteristics of the smooth-surfaced vesicles so that contamination of the rough-surfaced pellet with ralatively large, smooth-surfaced vesicies was greatly increased. However, this change was not accompanied by strictly proportional decreases in enzyme activity in SSM and increases in RSM. Thus, 3-MC-induced changes in levels of enzyme activity in microsomal subfractions cannot be explained solely on the basis of changes in the morphologic purity of the two subfractions.

Submitted on November 29, 1966
Accepted on February 27, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.